Combination therapies against cancer targeting CD38 and TGF-β
Grant
US12590167B2
Kind: B2
Mar 31, 2026
Assignee
Sanofi
Inventors
Francisco Adrian, Richard C. Gregory, Gary Shapiro, Helgi Van De Velde
Abstract
The present disclosure relates to combination cancer therapies targeting CD38 and TGF-β using antibodies specific for these targets. Also provided are compositions useful in the therapies.
CPC Classifications
C07K 16/2896
C07K 16/22
C07K 2317/565
C07K 2317/732
C07K 2317/76
A61K 31/12
A61K 2039/507
A61K 31/573
A61P 35/00
Filing Date
2019-07-10
Application No.
17259135
Claims
11